化合物Glasdegib T6514
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
25 mg | 1095173-27-5 | ¥3,220.00 | 询底价 |
1 mg | 1095173-27-5 | ¥398.00 | 询底价 |
1 mL | 1095173-27-5 | ¥983.00 | 询底价 |
10 mg | 1095173-27-5 | ¥1,530.00 | 询底价 |
100 mg | 1095173-27-5 | ¥6,790.00 | 询底价 |
50 mg | 1095173-27-5 | ¥4,770.00 | 询底价 |
5 mg | 1095173-27-5 | ¥913.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Glasdegib
描述: Glasdegib (PF-04449913) 是一种口服具有活力的 smoothened 抑制剂,能够结合到人 SMO(181-787氨基酸位点),IC50=4 nM。
细胞实验: PF-04449913 is dissolved in DMSO and stored, and then diluted with appropriate medium before use[1]. Normal or BC CML CD34+ cells are plated on confluent mitomycin-C treated SL/M2 cells with vehicle, PF-04449913 (1 μM), Dasatinib (50 nM), or combination treatment. Mouse bone marrow stromal cell lines, M2-10B4 (M2) and SL/SL (SL) are treated with mitomycin-C (1 mg/mL) and plated in a 1:1 mixture at a total concentration of 100,000 cells/mL one day prior to co-culture with 10,000-20,000 CD34+ BC CML or normal progenitors. After 1 week of culture, progenitors are FACS sorted into hematopoietic progenitor assays and colonies are scored at 14 days. To assess survival of normal human hematopoietic stem and progenitor cells, irradiated (20 Gray) OP9 (M2 clone) stromal cells are co-cultured with 50,000 human CD34+ cord blood cells, vehicle or PF-04449913 in AlphaMEM with 20% Hyclone FBS, 1% pen strep glutamine and supplemented with 50 ng/mL SCF, 10 ng/mL thrombopoietin, and 10 ng/mL Flt3 and quantified by weekly FACS analysis[1].
体外活性: In vitro microsomal assays, PF-04449913 have high clearance in rat and low clearance in dog and human, without inhibiting any of the major cytochrome P450 isoforms. [1]
体内活性: In rat and dog, PF-04449913 shows high clearance, and good oral bioavailability. [1]
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: H2O : < 1 mg/mL (insoluble or slightly soluble)
Ethanol : < 1 mg/mL (insoluble or slightly soluble)
DMSO : 44 mg/mL (117.5 mM)
关键字: Inhibitor | PF04449913 | inhibit | Smoothened | Smo | PF 04449913 | Glasdegib
相关产品: MRT-10 | SAG dihydrochloride | CUR61414 | HhAntag | Taladegib | BMS-833923 | Ellagic acid | TAK-441 | Jervine | MK-4101
相关库: Drug Repurposing Compound Library | Approved Drug Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | GPCR Compound Library | Inhibitor Library | Anti-Cancer Clinical Compound Library | Anti-Cancer Approved Drug Library | Anti-Cancer Active Compound Library | EMA Approved Drug Library
化合物Glasdegib T6514信息由TargetMol中国为您提供,如您想了解更多关于化合物Glasdegib T6514报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途